Nykredit A/S’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.6K Hold
1,839
– – ﹤0.01% 1686
2026
Q2
$27.1K Buy
+1,839
New +$12.7K ﹤0.01% 1643

Other funds holding SLS

Nykredit A/S's SLS Position: Q3 2026 in Review

Nykredit A/S held its SELLAS Life Sciences (SLS) position steady in Q3 2026 at 1,839 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Nykredit A/S first reported a position in SLS in Q2 2026 and has held it in 2 quarters since. The position peaked at $27.1K in Q2 2026. 213 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Nykredit A/S held 1,839 shares of SELLAS Life Sciences worth $22.6K as of Q3 2026.
  • Nykredit A/S left its SELLAS Life Sciences share count unchanged in Q3 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Nykredit A/S's portfolio in Q3 2026, its #1686 holding.
  • Nykredit A/S first reported a position in SELLAS Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • Nykredit A/S's SELLAS Life Sciences position peaked at $27.1K in Q2 2026.
  • 213 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.